| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_052090cc7db56227ba0673783194227a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-16 |
| filingDate |
2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0262dde00b904376032b812be7be0ee2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01fe96bfd6b54c223ae68e825c8df621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee12d5ba39f1b0903fa1740da8688a2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa2444c93d14de6512198a9f0a3e3b92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6660c0fee14f21e8ddfa64845a208bc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6250e7e629fefe05512630042dd2339 |
| publicationDate |
2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022083707-A1 |
| titleOfInvention |
Pharmaceutical use of fxia inhibitor compound or salt thereof |
| abstract |
Provided is a pharmaceutical use of an FXIa inhibitor compound or a salt thereof. Specifically, provided is a use of the FXIa inhibitor compound or the salt thereof in preparation of drugs for prevention and/or treatment of arterial and venous thrombosis. |
| priorityDate |
2020-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |